| Description | Rizatriptan-d6 is intended for use as an internal standard for the quantification of rizatriptan by GC- or LC-MS. Rizatriptan is an agonist of the serotonin receptor subtypes 5-HT1B and 5-HT1D. It is selective for 5-HT1B and 5-HT1D receptors over 5-HT1A receptors. Rizatriptan induces vasoconstriction in isolated human middle meningeal arteries. In vivo, rizatriptan reduces head grooming, the number of oculotemporal strokes, eye blinking, and one-eye closures in a Cacna1a mutant transgenic mouse model of migraine. Formulations containing rizatriptan have been used in the treatment of migraine. |
| molecular weight | 397.5116 |
| Molecular formula | C22H19D6N5O2 |
| CAS | 1216984-85-8 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 years |
Rizatriptan-d6 benzoate salt
CAS No.: 1216984-85-8
Rizatriptan-d6 is intended for use as an internal standard for the quantification of rizatriptan by GC- or LC-MS. Rizatr
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.